Ventas, Inc. (NYSE:VTR – Get Free Report) CEO Debra Cafaro sold 10,322 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.26, for a total transaction of $797,477.72. Following the completion of the sale, the chief executive officer owned 1,145,695 shares of the company’s stock, valued at approximately $88,516,395.70. This represents a 0.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.
Ventas Stock Down 0.5%
VTR stock traded down $0.39 during trading on Tuesday, hitting $76.05. 2,817,053 shares of the company’s stock traded hands, compared to its average volume of 3,096,684. The firm has a market capitalization of $35.72 billion, a P/E ratio of 146.25, a PEG ratio of 1.79 and a beta of 0.78. Ventas, Inc. has a 1 year low of $56.68 and a 1 year high of $81.89. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. The business has a fifty day simple moving average of $77.98 and a two-hundred day simple moving average of $71.08.
Ventas (NYSE:VTR – Get Free Report) last announced its earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter last year, the firm earned $0.80 EPS. The business’s revenue for the quarter was up 20.5% on a year-over-year basis. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Sell-side analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current year.
Ventas Dividend Announcement
Hedge Funds Weigh In On Ventas
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in VTR. Aberdeen Group plc grew its stake in Ventas by 2.5% during the 2nd quarter. Aberdeen Group plc now owns 1,460,098 shares of the real estate investment trust’s stock worth $90,409,000 after purchasing an additional 35,965 shares in the last quarter. Nicola Wealth Management LTD. purchased a new position in shares of Ventas in the 1st quarter valued at about $1,169,000. Investment Management Corp of Ontario grew its position in shares of Ventas by 1,019.0% during the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock worth $8,403,000 after buying an additional 121,170 shares in the last quarter. SCS Capital Management LLC acquired a new position in shares of Ventas during the second quarter worth about $13,788,000. Finally, Hudson Bay Capital Management LP purchased a new position in Ventas in the second quarter worth approximately $17,568,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.
Analysts Set New Price Targets
Several research analysts recently commented on VTR shares. Wells Fargo & Company boosted their price objective on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Jefferies Financial Group reaffirmed a “buy” rating and set a $93.00 price target on shares of Ventas in a research report on Monday, December 15th. UBS Group initiated coverage on Ventas in a research report on Friday, September 19th. They issued a “neutral” rating and a $73.00 price objective for the company. Scotiabank upped their target price on Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a research report on Thursday, November 13th. Finally, KeyCorp increased their price target on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.81.
Check Out Our Latest Stock Analysis on VTR
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A month before the crash
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- The $100 Trillion AI Story No One Is Telling You
- S&P 8000
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
